Vinva Investment Management Ltd Reduces Stock Holdings in Cencora, Inc. $COR

Vinva Investment Management Ltd reduced its position in shares of Cencora, Inc. (NYSE:COR) by 9.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,581 shares of the company’s stock after selling 4,461 shares during the period. Vinva Investment Management Ltd’s holdings in Cencora were worth $13,426,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. United Bank boosted its holdings in Cencora by 4.5% in the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares during the last quarter. Crestwood Advisors Group LLC increased its holdings in shares of Cencora by 18.9% during the 2nd quarter. Crestwood Advisors Group LLC now owns 1,376 shares of the company’s stock worth $413,000 after buying an additional 219 shares during the last quarter. Savant Capital LLC increased its holdings in shares of Cencora by 8.4% during the 2nd quarter. Savant Capital LLC now owns 8,251 shares of the company’s stock worth $2,474,000 after buying an additional 639 shares during the last quarter. Vestmark Advisory Solutions Inc. purchased a new stake in shares of Cencora during the 2nd quarter valued at approximately $4,233,000. Finally, Fox Run Management L.L.C. purchased a new stake in shares of Cencora during the 2nd quarter valued at approximately $448,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cencora

In other news, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the sale, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Silvana Battaglia sold 1,677 shares of Cencora stock in a transaction on Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the completion of the transaction, the executive vice president owned 18,796 shares of the company’s stock, valued at approximately $6,484,620. This trade represents a 8.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 15,220 shares of company stock valued at $5,282,867. 0.38% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on COR. Wall Street Zen lowered Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Robert W. Baird set a $415.00 target price on Cencora in a research report on Tuesday, January 13th. Wells Fargo & Company upped their price target on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Finally, TD Cowen raised their price objective on Cencora from $350.00 to $400.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Eleven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and an average target price of $399.00.

Cencora Stock Down 0.4%

Shares of COR opened at $357.98 on Friday. The company’s 50-day simple moving average is $354.16 and its 200-day simple moving average is $336.45. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. Cencora, Inc. has a 1 year low of $251.94 and a 1 year high of $377.54. The stock has a market capitalization of $69.64 billion, a PE ratio of 43.03, a P/E/G ratio of 1.67 and a beta of 0.68.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.73 earnings per share. Analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were paid a $0.60 dividend. The ex-dividend date was Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. Cencora’s payout ratio is 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.